» Articles » PMID: 3517268

Antigen Detection Test for Streptococcal Pharyngitis: Evaluation of Sensitivity with Respect to True Infections

Overview
Journal J Pediatr
Specialty Pediatrics
Date 1986 May 1
PMID 3517268
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The clinical significance of false-negative results on antigen detection tests for group A beta-hemolytic streptococcal (GABHS) pharyngitis (negative test results and positive culture) has yet to be determined. We recently compared the Culturette Brand Ten-Minute Group A Strep ID Kit with blood agar cultures in 313 patients with pharyngitis, 257 (82%) of whom had positive throat cultures for GABHS. The Culturette Brand test had a sensitivity of 88%, specificity of 96%, a positive predictive value of 99%, and negative predictive value of 64%. More than half of the false-negative Culturette Brand test results occurred in children with less than 10 GABHS colonies on throat culture (1+ culture). When these 1+ cultures were not considered positive, the sensitivity of the Culturette Brand test was 93%. The sensitivity of the Culturette Brand test increased with an increased degree of positivity of the corresponding throat culture. Of the 31 children with false-negative Culturette Brand test results, 14 (45%) had a significant streptococcal antibody response; of the 224 children with true-positive Culturette Brand test results (positive test results and positive culture) from whom serologic data were available, 114 (51%) had a significant streptococcal antibody response. This difference is not statistically significant. These findings suggest that almost half of patients with false-negative results on antigen detection tests for GABHS pharyngitis have true infections (positive culture and antibody rise) and are not merely streptococcal carriers.

Citing Articles

Prospective Evaluation of Xpert® Xpress Strep A Automated PCR Assay vs. Solana® Group A Streptococcal Nucleic Acid Amplification Testing vs. Conventional Throat Culture.

Ferrieri P, Thonen-Kerr E, Nelson K, Arbefeville S Curr Microbiol. 2021; 78(8):2956-2960.

PMID: 34085100 PMC: 8174534. DOI: 10.1007/s00284-021-02547-0.


Diagnosis and treatment of group a streptococcal pharyngitis.

Tanz R, Shulman S Semin Pediatr Infect Dis. 2020; 6(2):69-78.

PMID: 32288448 PMC: 7128789. DOI: 10.1016/S1045-1870(05)80054-8.


Detection of group a Streptococcus in pharyngitis by two rapid tests: comparison of the BD Veritor™ and the QuikRead go® Strep A.

Azrad M, Danilov E, Goshen S, Nitzan O, Peretz A Eur J Clin Microbiol Infect Dis. 2019; 38(6):1179-1185.

PMID: 30852698 DOI: 10.1007/s10096-019-03527-w.


Outpatient Antibiotic Stewardship: A Growing Frontier-Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use.

Joseph P, Godofsky E Open Forum Infect Dis. 2018; 5(2):ofy024.

PMID: 29479553 PMC: 5815119. DOI: 10.1093/ofid/ofy024.


Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections.

Self W, Rosen J, Sharp S, Filbin M, Hou P, Parekh A J Clin Med. 2017; 6(10).

PMID: 28991170 PMC: 5664009. DOI: 10.3390/jcm6100094.